Ilumya (tildrakizumab or tildrakizumab-asmn) is used to treat plaque psoriasis in adults. It's a type of monoclonal antibody called an interleukin-23 antagonist. It works by lowering inflammation in the skin. This medication is given as an injection under the skin every 3 months by a healthcare professional. Some people might have upper respiratory tract infections as a side effect. Ilumya (tildrakizumab) is only available as a brand-name medication.
Moderate-to-severe plaque psoriasis
Ilumya (tildrakizumab) is a type of monoclonal antibody. In particular, it's an interleukin-23 antagonist, or IL-23 inhibitor for short. It blocks IL-23, a protein that causes inflammation in the body.
By blocking IL-23, Ilumya (tildrakizumab) helps lower skin inflammation. This helps treat symptoms of plaque psoriasis.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Only given every 3 months, after the first two doses
Few side effects
Needs to be injected by a healthcare professional, not on your own at home
Not approved for other skin problems or autoimmune conditions
Mark your calendar with your appointments for your Ilumya (tildrakizumab) injections. The first 2 injections are given a month apart. Then, the rest of the injections are given every 3 months. Regular check-ins with your care team give you a chance to talk about how well the medication is working and any side effects that bother you.
You'll get Ilumya (tildrakizumab) injected under the skin of your stomach, thigh, or upper arm. After the injection, the area might be red, itchy, swollen, or sore or feel warm to the touch. These reactions usually go away on their own after a couple days. You can use hot or cold packs or over-the-counter pain relievers to help. But let your care team know if it bothers you too much or if it gets worse after a day.
Ilumya (tildrakizumab) can make it easier for you to get an infection. Call your care team right away if you have a fever, chills, sweating weakness, cough, trouble breathing, or diarrhea. These could be signs of an infection. Your care team can check if you need to get treated for the infection. You might have to stop Ilumya (tildrakizumab) so your body can fight the infection better.
Before getting any vaccines, tell your prescriber or pharmacist that you're taking Ilumya (tildrakizumab). They can help make sure the vaccine is safe for you. You shouldn't get live vaccines while taking this medication. It's not known if Ilumya (tildrakizumab) can make you more likely to get sick from a live vaccine.
Talk to your prescriber if you become pregnant or want to breastfeed while taking Ilumya (tildrakizumab). It isn't fully known if this medication is safe while pregnant or breastfeeding. Your prescriber can help you understand the risks and benefits.
Ilumya (tildrakizumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Severe allergic reactions to Ilumya (tildrakizumab) are possible. This can include hives and swelling in the face, lips, tongue, or around the eyes. It can also include tightness in the throat, closing of the throat, or trouble breathing. Get medical help right away if you notice any signs of a serious allergic reaction at any time. You'll have to stop Ilumya (tildrakizumab) and find another option.
Risk factors: Current infection | Long-term infection | Infection that keeps coming back | Other conditions that raise your risk of infection | Taking medications that weaken your immune system
Ilumya (tildrakizumab) can affect your body's ability to fight off infections. This can raise your risk of getting an infection. They can include upper respiratory tract infections like a cold. This medication might also raise the risk of more serious infections, such as tuberculosis (TB). It might also make it more likely for a TB infection you've had in the past to come back.
Before starting Ilumya (tildrakizumab), tell your care team about any medical conditions or infections you have. Some conditions can weaken your immune system and make it easier to get an infection. If you're sick, you might need to wait until the infection is gone before starting this medication. You'll also need to get tested for TB and possibly take antibiotics to treat it before you can start Ilumya (tildrakizumab).
Get medical care if you have signs of an infection while taking Ilumya (tildrakizumab). Look out for fever, cough, trouble breathing, weakness, sweating, chills, and confusion. You might have to stop Ilumya (tildrakizumab) so your body can fight the infection.
It's best to be up to date on all your vaccines before starting Ilumya (tildrakizumab). Tell your healthcare professional that you're taking Ilumya (tildrakizumab) before getting any vaccines.
Avoid live vaccines while taking Ilumya (tildrakizumab). It's not known if they're safe to get during treatment. Some examples of live vaccines are the nasal spray flu vaccine (FluMist), Varivax (chickenpox vaccine), and MMR (measles, mumps, and rubella vaccine).
Ilumya (tildrakizumab) is an injection given by a healthcare professional at a medical office. It's injected under the skin of your stomach, thigh, or upper arm.
The typical dose is 100 mg (1 injection) once, 1 month later, and then every 3 months after that.
Moderate-to-severe plaque psoriasis in adults
Psoriatic arthritis in adults
Moderate-to-severe Crohn's disease in adults
Moderate-to-severe ulcerative colitis in adults
Moderate-to-severe plaque psoriasis
Active psoriatic arthritis
Moderate-to-severe ulcerative colitis (UC)
Moderate-to-severe Crohn's disease (CD)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.